B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 7 690 KRW 1.85% Market Closed
Market Cap: 433B KRW
Have any thoughts about
BioPlus Co Ltd?
Write Note

BioPlus Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioPlus Co Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
B
BioPlus Co Ltd
KOSDAQ:099430
Cash from Operating Activities
â‚©16B
CAGR 3-Years
17%
CAGR 5-Years
38%
CAGR 10-Years
N/A
SD Biosensor Inc
KRX:137310
Cash from Operating Activities
-â‚©242.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
HLB Inc
KOSDAQ:028300
Cash from Operating Activities
-â‚©117.8B
CAGR 3-Years
-24%
CAGR 5-Years
-26%
CAGR 10-Years
-48%
T
T&L Co Ltd
KOSDAQ:340570
Cash from Operating Activities
â‚©32.6B
CAGR 3-Years
52%
CAGR 5-Years
39%
CAGR 10-Years
N/A
H
Humasis Co Ltd
KOSDAQ:205470
Cash from Operating Activities
â‚©26.7B
CAGR 3-Years
-34%
CAGR 5-Years
117%
CAGR 10-Years
N/A
I
Interojo Co Ltd
KOSDAQ:119610
Cash from Operating Activities
â‚©15.8B
CAGR 3-Years
21%
CAGR 5-Years
-5%
CAGR 10-Years
13%
No Stocks Found

BioPlus Co Ltd
Glance View

Market Cap
433B KRW
Industry
Health Care

BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.

Intrinsic Value
15 791.58 KRW
Undervaluation 51%
Intrinsic Value
Price
B

See Also

What is BioPlus Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
16B KRW

Based on the financial report for Dec 31, 2023, BioPlus Co Ltd's Cash from Operating Activities amounts to 16B KRW.

What is BioPlus Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
38%

Over the last year, the Cash from Operating Activities growth was 20%. The average annual Cash from Operating Activities growth rates for BioPlus Co Ltd have been 17% over the past three years , 38% over the past five years .

Back to Top